US2016338707A1PendingUtilityA1

Atraumatic Occlusion Balloons and Skirts, and Methods of Use Thereof

Assignee: GENZYME CORPPriority: Sep 11, 2006Filed: Dec 18, 2015Published: Nov 24, 2016
Est. expirySep 11, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61B 17/12136A61B 17/08A61B 17/12031A61B 17/1204A61B 17/12195A61B 17/12045A61B 17/12109A61B 17/12131A61B 2017/1205A61M 2025/1052A61B 17/12186A61M 29/02
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

One aspect of the present invention relates to catheters that can be placed in or around bodily conduits to occlude or widen a biological lumen without imparting significant trauma to the lumen. In certain embodiments, the invention particularly relates to the use of a polymer composition which can be made to gel upon insertion into said balloon or skirt. In certain embodiments, the inflating viscous polymer composition is a liquid at room temperature and a gel at mammalian physiological temperature. In certain embodiments, the inflating viscous polymer composition comprises an optionally purified inverse thermosensitive polymer.

Claims

exact text as granted — not AI-modified
1 . A method of occluding, widening or stenting a lumen in a mammal, comprising the steps of:
 positioning a catheter into said mammalian lumen at a location, wherein said catheter comprises an elongated shaft having an inflation lumen and a balloon connected to a distal end of the elongated shaft so that an interior chamber of the balloon is in fluid communication with the inflation lumen; and wherein an open proximal end of the balloon is in fluid communication with said mammalian lumen;   deploying said balloon, via said inflation lumen, with a composition comprising at least one polymer by introducing the composition in a manner sufficient to expand the balloon, wherein said composition gels partially or completely in said balloon.   
     
     
         2 . The method of  claim 1 , wherein said method is substantially atraumatic to said mammalian lumen. 
     
     
         3 . The method of  claim 1 , wherein said mammalian lumen is temporarily occluded. 
     
     
         4 . The method of  claim 1 , wherein said mammalian lumen is permanently occluded. 
     
     
         5 . The method of  claim 1 , wherein said at least one polymer is at least one purified inverse thermo sensitive polymer. 
     
     
         6 . The method of  claim 5 , wherein said purified inverse thermosensitive polymer has a polydispersity index from about 1.5 to about 1.0. 
     
     
         7 . The method of  claim 5 , wherein said purified inverse thermosensitive polymer has a polydispersity index from about 1.2 to about 1.0. 
     
     
         8 . The method of  claim 5 , wherein said purified inverse thermo sensitive polymer has a polydispersity index from about 1.1 to about 1.0. 
     
     
         9 . The method of  claim 5 , wherein said purified inverse thermo sensitive polymer is a polyoxyalkylene block copolymer. 
     
     
         10 . The method of  claim 5 , wherein said purified inverse thermo sensitive polymer is selected from the group consisting of poloxamers and poloxamines. 
     
     
         11 . The method of  claim 5 , wherein said purified inverse thermosensitive polymer is selected from the group consisting of poloxamer 407, poloxamer 338, poloxamer 118, Tetronic® 1107 and Tetronic® 1307. 
     
     
         12 . The method of  claim 5 , wherein said purified inverse thermo sensitive polymer is poloxamer 407. 
     
     
         13 . The method of  claim 1 , wherein said mammal is a human. 
     
     
         14 . The method of  claim 1 , wherein said mammalian lumen is an artery, a vein, a kidney, a gall bladder, a ureter, a urinary bladder, a pancreatic duct, a fallopian tube, a sinus, a tear duct, a salivary gland, lumens or other cavities of the lymphatic system, a colon, a small intestine or a large intestine. 
     
     
         15 . The method of  claim 1 , wherein said mammalian lumen is an artery. 
     
     
         16 . The method of  claim 1 , wherein said mammalian lumen is a gun shot wound or a laceration. 
     
     
         17 . The method of  claim 1 , wherein said mammalian lumen is calcified. 
     
     
         18 . The method of  claim 1 , wherein said method is part of a surgical procedure; and said location is a surgical site. 
     
     
         19 . The method of  claim 18 , wherein said surgical site is at or proximal to a hemorrhage, cancerous tissue, tumor, or organ. 
     
     
         20 . The method of  claim 18 , wherein said surgical procedure comprises anastomosis. 
     
     
         21 - 22 . (canceled)

Join the waitlist — get patent alerts

Track US2016338707A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.